Pathology, Pathogenesis and Therapy of Growth Hormone (GH)-producing Pituitary Adenomas: Technical Advances in Histochemistry and Their Contribution

  • Osamura Robert Y.
    Department of Pathology, Tokai University School of Medicine
  • Egashira Noboru
    Department of Pathology, Tokai University School of Medicine
  • Kajiya Hanako
    Department of Pathology, Tokai University School of Medicine
  • Takei Mao
    Department of Pathology, Tokai University School of Medicine Department of Neurosurgery, Nippon Medical School
  • Tobita Maya
    Department of Pathology, Tokai University School of Medicine Division of Diabetes, Metabolism and Endocrinology, Jikei University School of Medicine
  • Miyakoshi Takashi
    Department of Pathology, Tokai University School of Medicine
  • Inomoto Chie
    Department of Pathology, Tokai University School of Medicine
  • Takekoshi Susumu
    Department of Pathology, Tokai University School of Medicine
  • Teramoto Akira
    Department of Neurosurgery, Nippon Medical School

この論文をさがす

抄録

Growth hormone (GH)-producing adenomas (GHomas) are one of the most frequently-occurring pituitary adenomas. Differentiation of hormone-producing cells in the pituitary gland is regulated by transcription factors and co-factors. The transcription factors include Pit-1, Prop-1, NeuroD1, Tpit, GATA-2, SF-1. Aberrant expression of transcription factors such as Pit-1 results in translineage expression of GH in adrenocorticotropic hormone-producing adenomas (ACTHomas). This situation has been substantiated by GFP-Pit-1 transfection expression in the AtT20 cell line. Experimentally, GHomas have been induced in GH-releasing hormone (GHRH) or Prop-1 transgenic animals. Immunohistochemical detection of somatostatin receptor (SSTR2a) has recently emphasized their role in the response of GHomas to somatostatin analogue therapy. In this review, the advances in technology and their contribution to cell biology and medical practice are discussed.<br>

収録刊行物

被引用文献 (5)*注記

もっと見る

参考文献 (27)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ